Evidence map›Paper›PMID 39855268›Full record

ArticleApplied clinical informatics2025

Association of an HIV-Prediction Model with Uptake of Preexposure Prophylaxis.

Steven Romero, Kristin S Alvarez, Ank E Nijhawan, Arun Nethi, Katie Bistransin, Helen L King

Abstract read
In one paragraph

Article in Applied clinical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Identify Patients at Risk of HIV Using a Clinical Large Language Model from Electronic Health Records.Proceedings. IEEE International Conference on Healthcare Informatics · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Steven RomeroDepartment of Pharmacy, UT Southwestern Medical Center, Dallas TX and Parkland Health, Dallas, Texas, United States.
Kristin S AlvarezCenter of Innovation and Value at Parkland, Parkland Health, Dallas, Texas, United States.
Ank E NijhawanDivision of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas TX and Parkland Health, Dallas, Texas, United States.
Arun NethiParkland Center for Clinical Innovation, Dallas, Texas, United States.
Katie BistransinDepartment of Pharmacy, Parkland Health, Dallas, Texas, United States.
Helen L KingDivision of Infectious Diseases and Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas TX and Parkland Health, Dallas, Texas, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global efforts aimed at ending human immunodeficiency virus (HIV) incidence have adapted and evolved since the turn of the century. The utilization of machine learning incorporated into an electronic health record (EHR) can be refined into prediction models that identify when an individual is at greater HIV infection risk. This can create a novel and innovative approach to identifying patients eligible for preventative therapy.This study's aim was to evaluate the effectiveness of an HIV prediction model in clinical workflows. Outcomes included preexposure prophylaxis (PrEP) prescriptions generated and the model's ability to identify eligible patients.A prediction model was developed and implemented at the safety-net hospital in Dallas County. Patients seen in primary care clinics were evaluated between July 2020 and June 2022. The prediction model was incorporated into an existing best practice advisory (BPA) used to identify potentially eligible PrEP patients. The prior, basic BPA (bBPA) displayed if a prior sexually transmitted infection was documented, and the enhanced BPA (eBPA) incorporated the HIV prediction model.A total of 3,218 unique patients received the BPA during the study time period, with 2,346 ultimately included for evaluation. There were 678 patients in the bBPA group and 1,666 in the eBPA group. PrEP prescriptions generated increased in the postimplementation group within the 90-day follow-up period (bBPA:1.48 vs. eBPA:3.67 prescriptions per month,

Indexed as

HIV InfectionsPre-Exposure ProphylaxisAdultElectronic Health RecordsFemaleHumansMaleMiddle Aged

Identifiers

PMID39855268
PMCPMC12142452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.